Bioasis Technologies Inc. (BIOAF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0002 (-99.50%)
At close: Nov 10, 2025
Bioasis Technologies Market Cap
Bioasis Technologies has a market cap or net worth of $79 as of January 23, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
79.00
Enterprise Value
n/a
Revenue
199.01K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 4, 2012, Bioasis Technologies's market cap has decreased from 48.79M to 79.00, a decrease of -100.00%. That is a compound annual growth rate of -62.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 79.00 | -99.01% |
| Dec 31, 2024 | 7.94K | -97.87% |
| Dec 29, 2023 | 373.25K | -89.60% |
| Dec 30, 2022 | 3.59M | -76.54% |
| Dec 31, 2021 | 15.30M | -14.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RVL Pharmaceuticals | 111.00 |
| ContraFect | 107.00 |
| Notable Labs | 97.00 |
| Infinity Pharmaceuticals | 91.00 |
| American Oriental Bioengineering | 88.00 |
| RenovaCare | 87.00 |
| Cardax | 83.00 |
| Athersys | 62.00 |